AnaptysBio, Inc. ANAB Repurchase Of Common Stock Incurred But Not Yet Paid
Repurchase Of Common Stock Incurred But Not Yet Paid at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept anab:RepurchaseOfCommonStockIncurredButNotYetPaid.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s repurchase of common stock incurred but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s repurchase of common stock incurred but not yet paid?
- AnaptysBio, Inc. (ANAB) reported repurchase of common stock incurred but not yet paid of $0 in Q1 2026.
- How has AnaptysBio, Inc.'s repurchase of common stock incurred but not yet paid changed year-over-year?
- AnaptysBio, Inc.'s repurchase of common stock incurred but not yet paid decreased by 100.0% year-over-year, from $959K to $0.
- What does repurchase of common stock incurred but not yet paid mean?
- This represents the value of common stock repurchases that have been committed to or authorized but for which the cash payment has not yet been settled. It serves as a liability indicator for capital return programs. Monitoring this helps investors understand the company's pending obligations regarding shareholder return initiatives.